Engineered antibodies could cut chemotherapy risks
Friday, July 25, 2008 - 11:14
in Health & Medicine
Controlled drug attachment to antibodies lowers side-effects of cancer treatment
Read the whole article on Chemistry World
More from Chemistry World
Related
- JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in labWed, 29 Jul 2009, 17:39:03 EDT
- Antibody gives cancer the recognition it deservesWed, 22 Apr 2009, 15:16:09 EDT
- Antibody targeting of glioblastoma shows promise in preclinical tests, say Lombardi researchersFri, 31 Jul 2009, 10:00:06 EDT
- Adding epratuzumab to standard therapyFri, 16 May 2008, 11:22:04 EDT
- Scripps research team develops new technique to tap full potential of antibody librariesThu, 15 Jan 2009, 14:32:31 EST